Releases
Found 40776 articles
Parcel Perform Rebrands as Perform.AI to Automate E-commerce Operations
Singapore-based logistics software provider Parcel Perform is rebranding to Perform.AI, shifting its focus from simple parcel tracking to an end-to-end AI Commerce Operating System. The move reflects a new retail reality where brands must optimize their operations not just for human shoppers, but for the AI agents that influence purchase decisions.
Essity Sets October 22 Date for Q3 2026 Earnings Presentation
Stockholm-based hygiene and health giant Essity will release its financial performance data for the third quarter of 2026 on October 22. The report, scheduled for publication at 07:00 CET, precedes a formal presentation by company leadership intended to detail the firm's fiscal trajectory during the current year.
Beactica Therapeutics Advances Glioblastoma Drug BEA-17 to Regulatory Phase
Swedish precision medicine firm Beactica Therapeutics has launched IND-enabling studies for BEA-17, a first-in-class oral degrader targeting LSD1 and CoREST. This milestone moves the experimental glioblastoma treatment from preclinical proof-of-concept toward formal safety testing and regulatory filings required for human clinical trials in the United States and Europe.
Beactica Advances Glioblastoma Drug Candidate to Regulatory Testing
Swedish precision medicine firm Beactica Therapeutics has launched IND-enabling studies for BEA-17, a first-in-class oral degrader targeting LSD1 and CoREST to treat glioblastoma. This shift from preclinical research into rigorous safety and manufacturing protocols marks a critical step toward securing regulatory approval for upcoming first-in-human clinical trials.
PharmaResearch Expands REJURAN European Reach With Budapest Launch
Under the vaulted ceilings of Budapest’s Museum of Fine Arts, 100 aesthetic medicine professionals gathered on September 14 to mark the official entry of the Korean skin booster REJURAN into the Hungarian market, signaling a strategic push by PharmaResearch to deepen its footprint across the European continent.
IAB Tech Lab Targets Manual Ad Buying with New Agentic Standard
The IAB Tech Lab has unveiled AAMP 3.0, a framework designed to automate the gap between media RFPs and final buy commitments. By introducing the OpenProposal specification, the organization aims to replace manual, human-centric workflows with machine-readable protocols that allow AI agents to negotiate and evaluate ad inventory.
IAB Tech Lab Unveils AAMP 3.0 to Automate Media Buying
The IAB Tech Lab has introduced AAMP 3.0, a new framework designed to standardize the transition from advertising requests for proposals (RFPs) to finalized media buys. By replacing manual negotiations with machine-readable protocols, the update aims to integrate AI agents directly into the digital advertising planning and transaction lifecycle.
Rock Tech and Siemens Partner on Digital Lithium Processing in Ontario
Rock Tech Lithium has signed agreements with Siemens Canada to integrate advanced German digital engineering into its Red Rock Converter project in Ontario. This move marks a shift toward virtual plant modeling, aiming to optimize energy flows and material output before construction of the lithium facility begins.
EU Regulators Approve AbbVie’s Rinvoq for Pediatric Arthritis
The European Commission has authorized the use of Rinvoq for children aged two and older suffering from active polyarticular juvenile idiopathic arthritis. This approval introduces a new weight-based oral solution for patients who have failed to respond to standard disease-modifying anti-rheumatic drugs, marking a significant expansion for the medication.
Joe Ochoa of Creator TV to Discuss Sports Fandom at Marketecture Live
The traditional sports broadcast is losing its monopoly on fan attention, a shift that will take center stage at Marketecture Live in Chicago on September 23. Joe Ochoa, co-founder of Creator TV, joins a panel of industry experts to dissect how creators are reshaping the modern sports landscape.
Temu Enters Romanian Market Through ABSL Partnership
Temu has signed a Memorandum of Understanding with the Association of Business Service Leaders in Romania, marking a strategic pivot to embed its operations within the country's local business ecosystem. The deal positions the e-commerce giant to engage directly with a network ranging from startups to multinational corporations.
Volvo Cars adopts Horizon to accelerate software development
Volvo Cars has become the lead industry partner for Horizon, a new open-source platform developed by Accenture and Google Cloud. The collaboration aims to streamline the creation, testing, and deployment of Android Automotive Operating System software, allowing the automaker to replace legacy workflows with cloud-native virtual environments.
Taiwan’s CMUH Enters Global Neurosurgery Rankings
China Medical University Hospital has secured a spot on Newsweek’s World’s Best Specialized Hospitals 2027 list for neurosurgery, marking the first time a Taiwanese institution has entered this specific global ranking. The hospital joins an elite group of 125 facilities recognized for excellence in complex neurological care and innovation.
Anyang Indorama Secures $358 Million for Fertilizer Expansion
Anyang Indorama Gases has finalized a 2.4 billion RMB, or approximately 358 million USD, long-term loan facility to fund a major fertilizer production expansion in Henan Province. The capital injection marks a strategic pivot for the Singapore-based subsidiary as it looks to double its domestic urea output by 2029.
Corvex Management Calls for Board Seat at Whitbread PLC
Corvex Management has requisitioned a general meeting of Whitbread PLC shareholders to appoint partner James Gemmel to the company’s board. As the hospitality firm's largest active shareholder, holding a 7% economic interest, the investment firm argues that direct representation is necessary to address years of underperformance and stagnant returns.
ExploRNA and Łukasiewicz-IChP Partner for GMP mRNA Cap Production
Warsaw-based ExploRNA Therapeutics is joining forces with the Łukasiewicz Industrial Chemistry Institute to transition its proprietary mRNA capping technology into Good Manufacturing Practice production, a move designed to secure the supply chain for clinical-stage mRNA vaccines and advanced genetic medicines.
ExploRNA and Łukasiewicz-IChP Partner to Scale mRNA Cap Production
Warsaw-based biotech firm ExploRNA Therapeutics has joined forces with the Łukasiewicz Industrial Chemistry Institute to transition its proprietary mRNA cap analogs, including the AvantCap Q1 technology, into Good Manufacturing Practice production, bridging the gap between laboratory-scale innovation and the requirements of late-stage clinical trials.
Essity Sets October Date for Third Quarter 2026 Earnings Presentation
Stockholm-based hygiene and health giant Essity plans to release its financial results for the third quarter of 2026 on October 22. The company will host a live webcast and teleconference at 09:00 CET, two hours after the official publication of the report, to walk investors through the performance metrics.
Dutch cycling model faces pressure from light electric vehicles
As European Mobility Week concludes, Breda University of Applied Sciences researchers warn that the surge of light electric vehicles—from e-cargo bikes to fatbikes—threatens traditional cycle path safety. While these vehicles promise to reduce car dependency, they introduce new speed and mass variables that complicate the Netherlands' established infrastructure.
Dutch cycling paths face pressure from rising electric vehicle use
As European Mobility Week concludes, Breda University of Applied Sciences researchers warn that light electric vehicles are testing the limits of Dutch cycling infrastructure. While e-scooters and fatbikes offer a path to lower car dependency, their integration into narrow cycle lanes is driving a measurable increase in safety concerns.
UWM Holdings Faces Securities Fraud Class Action Over Hedging Risks
Investors who purchased UWM Holdings Corporation shares between March 9 and August 5, 2026, are being urged to join a class action lawsuit. Schall, Brown & Schwartz LLP claims the mortgage lender misled shareholders by concealing the extent of risks associated with its aggressive hedge position on mortgage servicing rights.
UWM Holdings Faces Securities Class Action Over Hedging Strategy
Investors who purchased UWM Holdings Corporation stock between March 9 and August 5, 2026, face an October 13 deadline to join a class action lawsuit. The litigation alleges the mortgage lender misled shareholders by abandoning its core strategy of avoiding hedges on mortgage servicing rights, resulting in undisclosed financial risks.
Skanska Secures $84 Million Contract for Georgia Data Center
A fresh $84 million contract puts Swedish construction giant Skanska at the helm of a massive data center expansion in Georgia. The project, commissioned by an existing client, marks a significant addition to the company’s third-quarter order bookings for 2026 as demand for high-capacity digital infrastructure continues to surge.
Alarum Technologies Faces Securities Class Action Over NetNut Privacy Claims
Investors who held Alarum Technologies Ltd. stock between March 20, 2025, and July 2, 2026, face an October 5 deadline to join a class action lawsuit. The litigation, spearheaded by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the operational practices of its NetNut subsidiary.
Investors File Class Action Against ARS Pharmaceuticals Over Neffy Delays
Investors who purchased ARS Pharmaceuticals stock between March 9 and June 24, 2026, face a critical October 5 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the timeline for critical formulary and coverage approvals for its product, neffy.
ARS Pharmaceuticals Faces Securities Class Action Over Neffy Disclosure
Investors who purchased ARS Pharmaceuticals stock between March 9 and June 24, 2026, face an October 5 deadline to join a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the insurance coverage timeline for its product, neffy.
Hylenr Concludes Phase 1 Validation of Lattice Confinement Fusion
In a controlled laboratory setting at Texas A&M University, researchers have completed the initial validation phase for Hylenr’s BRT-NiUCS-2 reactor. The study confirmed anomalous thermal performance and distinct noble-gas signatures within the lattice-based system, marking a departure from internal testing toward independent verification of the technology’s energy potential.
Capricor Therapeutics Faces Securities Litigation Over Drug Trial Data
Investors who held Capricor Therapeutics stock between October 9, 2024, and July 10, 2025, are being recruited for a class action lawsuit. The DJS Law Group alleges the biotech firm misled shareholders regarding the clinical progress and safety data of its deramiocel drug candidate during the HOPE-2 trial.
Datavault AI Faces Class Action Lawsuit Over Alleged Securities Fraud
Investors who purchased Datavault AI Inc. stock between September 4, 2024, and October 30, 2025, are being recruited for a class action lawsuit. The DJS Law Group alleges the company misled shareholders by inflating the value of its partnerships and misrepresenting trading volumes on its proprietary platform.
BiomeRenewables Secures US Patent for Owl-Inspired Blade Tech
The United States Patent and Trademark Office has officially allowed BiomeRenewables’ application for its FeatherEdge technology, a design that mimics the silent flight of an owl to dampen turbine noise. This patent adds a critical layer of protection to the Toronto-based startup’s expanding intellectual property portfolio.